Ebola virus mucin-like glycoprotein (Emuc) induces remarkable acute inflammation and tissue injury: evidence for Emuc pathogenicity <i>in vivo</i>

Yun-Jia Ning; Zhenyu Kang; Jingjun Xing; Yuan-Qin Min; Dan Liu; Kuan Feng; Manli Wang; Fei Deng; Yiwu Zhou; Zhihong Hu; Hualin Wang

doi:10.1007/s13238-017-0471-x

PDF(1744 KB)

Protein Cell ›› 2018, Vol. 9 ›› Issue (4) : 389-393. DOI: 10.1007/s13238-017-0471-x

LETTER

Ebola virus mucin-like glycoprotein (Emuc) induces remarkable acute inflammation and tissue injury: evidence for Emuc pathogenicity in vivo

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Yun-Jia Ning, Zhenyu Kang, Jingjun Xing, Yuan-Qin Min, Dan Liu, Kuan Feng, Manli Wang, Fei Deng, Yiwu Zhou, Zhihong Hu, Hualin Wang. Ebola virus mucin-like glycoprotein (Emuc) induces remarkable acute inflammation and tissue injury: evidence for Emuc pathogenicity in vivo. Protein Cell, 2018, 9(4): 389‒393 https://doi.org/10.1007/s13238-017-0471-x

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Baize S, Leroy EM, Georges AJ (2002) Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128:163–168 CrossRef Google scholar

[2]	Chan SY, Ma MC, Goldsmith MA (2000) Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol 81:2155–2159 CrossRef Google scholar

[3]	Cilloniz C, Ebihara H, Ni C (2011) Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol 85:9060–9068 CrossRef Google scholar

[4]	Feldmann H, Geisbert TW (2011) Ebola haemorrhagic fever. Lancet 377:849–862 CrossRef Google scholar

[5]	Francica JR, Matukonis MK, Bates P (2009) Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein. Virology 383:237–247 CrossRef Google scholar

[6]	He TC, Zhou SB, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509–2514 CrossRef Google scholar

[7]	Jeffers SA, Sanders DA, Sanchez A (2002) Covalent modifications of the ebola virus glycoprotein. J Virol 76:12463–12472 CrossRef Google scholar

[8]	Ning YJ, Deng F, Hu ZH, Wang HL (2017) The roles of ebolavirus glycoproteins in viral pathogenesis. Virol Sin 32:3–15 CrossRef Google scholar

[9]	Ohimain EI (2016) Recent advances in the development of vaccines for Ebola virus disease. Virus Res 211:174–185 CrossRef Google scholar

[10]	Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P (2002) Ebola virus glycoproteins induce global surface protein downmodulation and loss of cell adherence. J Virol 76:2518–2528 CrossRef Google scholar

[11]	Singh G, Kumar A, Singh K, Kaur J (2015) Ebola virus: an introduction and its pathology. Rev Med Virol 26(1):49–56 CrossRef Google scholar

[12]	Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y (2000) Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278:20–26 CrossRef Google scholar

[13]	Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ (2000) Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 6:886–889 CrossRef Google scholar

[14]	Zaki SR, Shieh WJ, Greer PW (1999) A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J Infect Dis 179:S36–S47 CrossRef Google scholar